Riskpilot← Back to searchSign inGet full accessImmunit Group Sweden AB
ABActiveOrg 5569793606Economic activity was not specified by tax authority · NACE 0000Est. 20140 employees
Revenue 2025
—
EBITDA margin
—
-248% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
SEK 937K
+197% vs 2024
| Revenue | — | — |
| EBITDA | SEK -27K | -248% |
| Net profit | SEK 937K | +197% |
| Total assets | SEK 1,1M | +307% |
| Equity | SEK 1,1M | +656% |
| Employees | 0 | — |
Legal name
Immunit Group Sweden AB
Org number
5569793606
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
13 augusti 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva bygg- och snickeriverksamhet, företrädesvis om-, ny- och tillbyggnationer samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 | −2 | −2 | −8 | −27 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −2 | −2 | −2 | −8 | −27 |
| Net financials | — | — | 1 000 | −963 | 964 |
| Profit before tax | −2 | −2 | 998 | −970 | 937 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −2 | −2 | 998 | −970 | 937 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 276 | 1 034 | 1 232 | 275 | 1 120 |
| Equity | 1 157 | 915 | 1 113 | 143 | 1 080 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 119 | 119 | 119 | 132 | 40 |
| Total debt | 119 | 119 | 119 | 132 | 40 |
EBITDA margin
-2672800.0%
This company
15.8%
Market median
-16916556% vs market
20212025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
86.8%
This company
18.4%
Market median
+372% vs market
20212025
Net profit margin
93690600.0%
This company
8.1%
Market median
+1156673974% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BS Chief Auditor | Chief Auditor | 2020 |
| Former (1) | ||
EJ | Audit | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Immunit Group Sweden AB 
Immunit Group ABBoard members of Immunit Group Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Barath Sivasson | Chief Auditor | 0 companies |
| Erik John-David Larsson | Audit | 0 companies |
| Hans Johan Sarsten | Chairman | 0 companies |
| Anna Matilda Sofi Umarlar | Deputy Board Member | 0 companies |
| Can Teoman Umarlar | Board of Directors | 0 companies |
| Mazdak Modjallal | Board of Directors | 0 companies |